Insider Stock Trading History of Chari Ravi S.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Chari Ravi S. since year 2005. The trader's CIK number is 1632795. At the time of this reporting, Chari Ravi S. is the SVP-Clinical Excellence of Hca Healthcare, Inc. . (stock ticker symbol HCA). See this page for all insider trading activities at Hca Healthcare, Inc. .


Stock purchases, sales, and option exercises reported by insider Chari Ravi S. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-02-25 HCA Hca Healthcare, Inc. Option Ex 930 .00 0
2018-02-05 HCA Hca Healthcare, Inc. Option Ex 500 .00 0
2018-01-31 HCA Hca Healthcare, Inc. Option Ex 14,850 55.92 830,456
2018-02-01 HCA Hca Healthcare, Inc. Sale 10,568 102.29 1,081,000
2018-02-02 HCA Hca Healthcare, Inc. Sale 5,702 102.01 581,655
2017-03-27 HCA Hca Healthcare, Inc. Option Ex 31,956 16.54 528,392
2017-03-27 HCA Hca Healthcare, Inc. Sale 31,956 90.00 2,876,040
2017-02-05 HCA Hca Healthcare, Inc. Option Ex 500 .00 0
2017-02-06 HCA Hca Healthcare, Inc. Option Ex 564 .00 0
2017-02-01 HCA Hca Healthcare, Inc. Sale 15,901 82.00 1,303,882
2017-01-17 HCA Hca Healthcare, Inc. Option Ex 42,500 44.27 1,881,262
2016-02-08 HCA Hca Healthcare, Inc. Option Ex 614 .00 0
2016-02-05 HCA Hca Healthcare, Inc. Option Ex 500 .00 0
2016-02-06 HCA Hca Healthcare, Inc. Option Ex 562 .00 0
2015-08-06 HCA Hca Healthcare, Inc. Sale 11,166 90.78 1,013,649
2015-08-06 HCA Hca Healthcare, Inc. Option Ex 11,166 9.69 108,165
2015-02-06 HCA Hca Healthcare, Inc. Option Ex 562 .00 0
2015-02-08 HCA Hca Healthcare, Inc. Option Ex 612 .00 0
2015-02-05 HCA Hca Healthcare, Inc. Option Ex 500 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chari Ravi S. (SVP-Clinical Excellence of Hca Healthcare, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.